Volume 90%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Play/PauseSPACE
Increase Volume
Decrease Volume
Seek Forward
Seek Backward
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Seek %0-9
00:00
00:00
00:00
 

Chapters

Transcript

Video

Katie Maurer, MD, PhD discusses HSCT treatment

Katie Maurer, MD, PhD, from Dana-Farber Cancer Institute, shared #ASH24 findings suggesting that diverse bone marrow cell composition may predict treatment response in the content of AML patients undergoing HSCT.

Related Presenters

Katie Maurer, MD.

Katie Maurer, MD

Medical Oncology

Katie Maurer is a Physician-Scientist at Dana-Farber Cancer Institute.

View full profile

ADVERTISEMENT

Related Videos